Phase
Condition
Colic
Treatment
L. reuteri
Placebo
Clinical Study ID
Ages 3-12 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Aged between 3-12 weeks at screening.
Gestational age 37+0 weeks - 42+0 weeks at birth.
Birth weight appropriate for gestational age (AGA - weight between 10th and 90thpercentile) or Large for Gestational Age (LGA - weight above the 90th percentile)determined using WHO Weight-for Age percentile guides.
Parents/caregivers/legal guardians are >18 years.
Exclusively or predominantly breastfed infants (> 50 % breast fed).
Willing to maintain current feeding patterns (not change formula/not change ratio offormula:breast milk etc.).
Readiness and the opportunity for parents/caregivers/legal guardians to fill out astudy diary, questionnaires.
Infantile colic diagnosed according to Rome IV criteria (face-to-face consult with aphysician, parents/caregivers/legal guardians must report that their infant hascried or fussed for 3 or more hours per day, during 3 or more days in the precedingweek). At Visit 2, this will be confirmed by Baby's Day Diary®, at least one 24-hourperiod should show 3 or more hours of crying/fussing time.
Parents/caregivers/legal guardians with ability to understand and comply with therequirements of the study, as judged by the Investigator.
Parents/caregivers/legal guardians willing and able to give informed consent fortheir and their infant's participation in the study.
The mother of the infant must be willing to attend Visit 2 (Day 0), Visit 3 (Day 8),and Visit 4 (Day 22).
Infant is considered healthy, in the opinion of the investigator following physicalexam.
Exclusion
Exclusion Criteria:
Infants with severe gastroesophageal reflux (throwing up or spitting up more than ateaspoon of milk > 8 times daily, projectile, bilious or bloody emesis).
Infants with failure to thrive, intrauterine growth retardation, haematochezia (blood in the stools), diarrhoea (watery stools that takes the shape of a container > 12x in breastfed and >5 in partially breastfed infants daily), or fever (38.0degrees), as reported by parents/caregivers/ legal guardians.
Infants with congenital heart disease, immunodeficiency, asplenia, cancer, cysticfibrosis, and those with liver disease.
Infants with reported exposure to probiotics in the 7 days prior to Screening Visit (V1) and throughout the study period.
Infants with reported exposure to oral and/or systemic antibiotics in the 7 daysprior to Screening Visit (V1) and throughout the study period.
Infants with reported exposure to medications, therapies, or products with the aimto relieve infantile colic including proton pump inhibitors in the 7 days prior toScreening Visit (V1) and throughout the study period.
Study Design
Connect with a study center
University of Salento, University Hospital Vito Fazzi Lecce
Lecce, LE 73100
ItalyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.